October 18, 2024
Vaccines to Prevent Pneumococcal Infection and Disease Pneumococcal disease is common in young children, but older adults are at the greatest risk of seriousillness and death. Pneumococcal pneumonia is the most common clinical manifestation of pneumococcal disease in adults. It leads to 150,000 US hospitalizations annually and is estimated to account for 10 to 30%…
December 14, 2022
Description: ASPRUZYO Sprinkle contains ranolazine, an antianginal available as white to off-white coated extended-release granules filled in unit-dose sachets containing 500 mg or 1000 mg. Indications & Dosage: ASPRUZYO Sprinkle is indicated for the treatment of chronic angina. ASPRUZYO Sprinkle may be used with beta-blockers, nitrates, calcium channel blockers, anti‑platelet therapy, lipid-lowering therapy, ACE inhibitors,…
October 3, 2022
REGRANEX® (BECAPLERMIN) GEL IS BACK IN STOCK FROM SMITH & NEPHEW, INC Description: REGRANEX® gel is the only FDA-approved PDGF for the treatment of diabetic neuropathic ulcers, formulated to act as a first-line treatment following effective ulcer care. REGRANEX® gel features endogenous platelet-derived growth factor (PDGF) therapy, shown to initiate the healing process by attracting…
January 4, 2022
PAXLOVID – Oral Antiviral Treatment for COVID-19 The FDA has recently granted emergency use authorization (EUA) for PAXLOVID. Paxlovid is nirmatrelvir tablets co-packaged with ritonavir tablets, both antiviral agents. Both agents must be administered together. In clinical trials, PAXLOVID significantly reduced the risk of hospitalization or death for any cause by 89% compared to placebo…
Categories
